UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity

European urology, 2008-06, Vol.53 (6), p.1245-1253

2008

Volltextzugriff (PDF)

The Dukes staging system: a cornerstone in the clinical management of colorectal cancer

The lancet oncology, 2009-11, Vol.10 (11), p.1128-1128

2009

Volltextzugriff (PDF)

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment

European urology, 2009-06, Vol.55 (6), p.1440-1449

2009

Volltextzugriff (PDF)

Botulinum injections for the treatment of bladder symptoms of multiple sclerosis

Annals of neurology, 2007-11, Vol.62 (5), p.452-457

2007

Volltextzugriff (PDF)

Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity

BJU international, 2008-09, Vol.102 (s1), p.17-19

2008

Volltextzugriff (PDF)

A COMPARISON BETWEEN THE RESPONSE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND NEUROGENIC DETRUSOR OVERACTIVITY TO THE FIRST INTRADETRUSOR INJECTION OF BOTULINUM-A TOXIN

The Journal of urology, 2005-09, Vol.174 (3), p.984-989

2005

Volltextzugriff (PDF)

Long-Term Effect on Quality of Life of Repeat Detrusor Injections of Botulinum Neurotoxin-A for Detrusor Overactivity in Patients With Multiple Sclerosis

The Journal of urology, 2011-04, Vol.185 (4), p.1344-1349

2011

Volltextzugriff (PDF)

Quality of Life Changes in Patients with Neurogenic versus Idiopathic Detrusor Overactivity after Intradetrusor Injections of Botulinum Neurotoxin Type A and Correlations with Lower Urinary Tract Symptoms and Urodynamic Changes

European urology, 2006-03, Vol.49 (3), p.528-535

2006

Volltextzugriff (PDF)

What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection

The Journal of urology, 2009-04, Vol.181 (4), p.1773-1778

2009

Volltextzugriff (PDF)

Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity

European urology, 2008-07, Vol.54 (1), p.181-187

2008

Volltextzugriff (PDF)

Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin‐A: is incomplete bladder emptying predictable?

BJU international, 2009-03, Vol.103 (5), p.630-634

2009

Volltextzugriff (PDF)

538 THE IMPLICATIONS OF INDETERMINATE PULMONARY NODULES ON STAGING CT IMAGING IN NEWLY DIAGNOSED RENAL CANCER

The Journal of urology, 2011-04, Vol.185 (4), p.e218-e218

2011

Volltextzugriff (PDF)

Comparison of the impact on health‐related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity

BJU international, 2011-06, Vol.107 (11), p.1786-1792

2011

Volltextzugriff (PDF)

Therapy Insight: bladder dysfunction associated with multiple sclerosis

Nature clinical practice urology, 2005-10, Vol.2 (10), p.492-501

2005

Volltextzugriff (PDF)

VIDEO‐GAMES STATION OR MINIMALLY INVASIVE SKILLS TRAINING STATION?

BJU international, 2009-07, Vol.104 (2), p.159-160

2009

Volltextzugriff (PDF)

Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre

European urology, 2006-03, Vol.49 (3), p.519-527

2006

Volltextzugriff (PDF)

Techniques for the intradetrusor administration of botulinum toxin

BJU international, 2006-04, Vol.97 (4), p.675-678

2006

Volltextzugriff (PDF)

ASSESSMENT OF URODYNAMICS AND DETRUSOR CONTRACTILITY FOLLOWING BOTULINUM TOXIN-A TREATMENT FOR OVERACTIVE BLADDER

The Journal of urology, 2008, Vol.179 (4), p.441-441

2008

Volltextzugriff (PDF)

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment. Commentary

European urology, 2009, Vol.55 (6), p.1440-1449

2009

Volltextzugriff (PDF)

Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies

Current medical research and opinion, 2006-05, Vol.22 (5), p.851

2006

Volltextzugriff (PDF)

Improving the global management of the neurogenic bladder patient: part I. The complexity of patients

Current medical research and opinion, 2006-02, Vol.22 (2), p.359-365

2006

Volltextzugriff (PDF)

Improving the global management of the neurogenic bladder patient: part II.Future treatment strategies

Current medical research and opinion, 2006-05, Vol.22 (5), p.851-860

2006

Volltextzugriff (PDF)

Female urology and neurourology

Viva Practice for the FRCS(Urol) and Postgraduate Urology Examinations, 2018, p.261-292

2018

Volltextzugriff (PDF)

Epidemiology of gallbladder cancer in India

Chinese Clinical Oncology, 2019-08, Vol.8 (4), p.33-33

2019

Volltextzugriff (PDF)

A Comprehensive Review on Bioactive Compounds Found in Caesalpinia sappan

Molecules (Basel, Switzerland), 2023-08, Vol.28 (17), p.6247

2023

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(34)
Buchkapitel
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Histological Changes in the Urothelium and Suburothelium of Human Overactive Bladder following Intradetrusor Injections of Botulinum Neurotoxin Type A for the Treatment of Neurogenic or Idiopathic Detrusor Overactivity

The Dukes staging system: a cornerstone in the clinical management of colorectal cancer

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment

Botulinum injections for the treatment of bladder symptoms of multiple sclerosis

Health economics and intradetrusor injections of botulinum for the treatment of detrusor overactivity

A COMPARISON BETWEEN THE RESPONSE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND NEUROGENIC DETRUSOR OVERACTIVITY TO THE FIRST INTRADETRUSOR INJECTION OF BOTULINUM-A TOXIN

Long-Term Effect on Quality of Life of Repeat Detrusor Injections of Botulinum Neurotoxin-A for Detrusor Overactivity in Patients With Multiple Sclerosis

Quality of Life Changes in Patients with Neurogenic versus Idiopathic Detrusor Overactivity after Intradetrusor Injections of Botulinum Neurotoxin Type A and Correlations with Lower Urinary Tract Symptoms and Urodynamic Changes

What a Patient With Refractory Idiopathic Detrusor Overactivity Should Know About Botulinum Neurotoxin Type A Injection

Early Effect on the Overactive Bladder Symptoms following Botulinum Neurotoxin Type A Injections for Detrusor Overactivity

Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin‐A: is incomplete bladder emptying predictable?

538 THE IMPLICATIONS OF INDETERMINATE PULMONARY NODULES ON STAGING CT IMAGING IN NEWLY DIAGNOSED RENAL CANCER

Comparison of the impact on health‐related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity

Therapy Insight: bladder dysfunction associated with multiple sclerosis

VIDEO‐GAMES STATION OR MINIMALLY INVASIVE SKILLS TRAINING STATION?

Cost-Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre

Techniques for the intradetrusor administration of botulinum toxin

ASSESSMENT OF URODYNAMICS AND DETRUSOR CONTRACTILITY FOLLOWING BOTULINUM TOXIN-A TREATMENT FOR OVERACTIVE BLADDER

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment. Commentary

Improving the global management of the neurogenic bladder patient: part II. Future treatment strategies

Improving the global management of the neurogenic bladder patient: part I. The complexity of patients

Improving the global management of the neurogenic bladder patient: part II.Future treatment strategies

Female urology and neurourology

Epidemiology of gallbladder cancer in India

A Comprehensive Review on Bioactive Compounds Found in Caesalpinia sappan

Suchergebnisse filtern